Renew Pharmaceuticals is an Irish company that supplies indocyanine green, a dye that glows under near-infrared light and helps surgeons see blood flow and tissue during operations. The FDA gave its dye orphan drug status as a diagnostic in liver cancer in 2026.
Renew Pharmaceuticals Ltd is based at the IDA Business and Technology Park in Athlone, Ireland. Its website says its portfolio under the Diagnostic Green brand includes indocyanine green (ICG) imaging agents and a hand-held near-infrared camera, the IC Flow Imaging System, for fluorescence-guided procedures, and that it is developing PerfusionWorks, AI software to quantify surgical fluorescence imaging; its news pages refer to the surgical platform UltraGreen.ai. On 30 September 2026 the FDA granted orphan drug designation to indocyanine green as a diagnostic for the management of hepatocellular carcinoma, with Renew Pharmaceuticals Limited as sponsor.
This is indocyanine green, a glowing dye, as developed by Renew Pharmaceuticals for liver cancer. The FDA has given it orphan drug status as a diagnostic for managing hepatocellular carcinoma, the commonest liver cancer.
Shares Fluorescence-guided surgery, Hepatocellular carcinoma.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/